208 related articles for article (PubMed ID: 12609901)
1. Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2003 Mar; 84(3):1985-97. PubMed ID: 12609901
[TBL] [Abstract][Full Text] [Related]
2. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
[TBL] [Abstract][Full Text] [Related]
3. Familial mutations and the thermodynamic stability of the recombinant human prion protein.
Swietnicki W; Petersen RB; Gambetti P; Surewicz WK
J Biol Chem; 1998 Nov; 273(47):31048-52. PubMed ID: 9813003
[TBL] [Abstract][Full Text] [Related]
4. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
5. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
Vanik DL; Surewicz WK
J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
[TBL] [Abstract][Full Text] [Related]
6. β-cleavage of the human prion protein impacts Cu(II) coordination at its non-octarepeat region.
Sánchez-López C; Quintanar L
J Inorg Biochem; 2022 Mar; 228():111686. PubMed ID: 34929540
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
Apetri AC; Vanik DL; Surewicz WK
Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
[TBL] [Abstract][Full Text] [Related]
8. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
9. Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization.
Steunou S; Chich JF; Rezaei H; Vidic J
Biosens Bioelectron; 2010 Dec; 26(4):1399-406. PubMed ID: 20692152
[TBL] [Abstract][Full Text] [Related]
10. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
[TBL] [Abstract][Full Text] [Related]
11. Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein.
Jones CE; Abdelraheim SR; Brown DR; Viles JH
J Biol Chem; 2004 Jul; 279(31):32018-27. PubMed ID: 15145944
[TBL] [Abstract][Full Text] [Related]
12. Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions.
Thakur AK; Srivastava AK; Srinivas V; Chary KVR; Rao CM
J Biol Chem; 2011 Nov; 286(44):38533-38545. PubMed ID: 21900252
[TBL] [Abstract][Full Text] [Related]
13. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.
Ricchelli F; Buggio R; Drago D; Salmona M; Forloni G; Negro A; Tognon G; Zatta P
Biochemistry; 2006 May; 45(21):6724-32. PubMed ID: 16716083
[TBL] [Abstract][Full Text] [Related]
14. A doppel alpha-helix peptide fragment mimics the copper(II) interactions with the whole protein.
La Mendola D; Magrì A; Campagna T; Campitiello MA; Raiola L; Isernia C; Hansson O; Bonomo RP; Rizzarelli E
Chemistry; 2010 Jun; 16(21):6212-23. PubMed ID: 20411530
[TBL] [Abstract][Full Text] [Related]
15. Copper(II) binding to the human Doppel protein may mark its functional diversity from the prion protein.
Cereghetti GM; Negro A; Vinck E; Massimino ML; Sorgato MC; Van Doorslaer S
J Biol Chem; 2004 Aug; 279(35):36497-503. PubMed ID: 15218028
[TBL] [Abstract][Full Text] [Related]
16. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
Rossetti G; Giachin G; Legname G; Carloni P
Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
[TBL] [Abstract][Full Text] [Related]
17. Insertion of beta-alanine in model peptides for copper binding to His96 and His111 of the human prion protein.
Rivillas-Acevedo L; Maciel-Barón L; García JE; Juaristi E; Quintanar L
J Inorg Biochem; 2013 Sep; 126():104-10. PubMed ID: 23796442
[TBL] [Abstract][Full Text] [Related]
18. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
Redecke L; Meyer-Klaucke W; Koker M; Clos J; Georgieva D; Genov N; Echner H; Kalbacher H; Perbandt M; Bredehorst R; Voelter W; Betzel C
J Biol Chem; 2005 Apr; 280(14):13987-92. PubMed ID: 15684434
[TBL] [Abstract][Full Text] [Related]
20. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.
Miura T; Hori-i A; Mototani H; Takeuchi H
Biochemistry; 1999 Aug; 38(35):11560-9. PubMed ID: 10471308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
